Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use.
dc.contributor.author | Higgins, Mark | |
dc.contributor.author | Morgan-John, Sam | |
dc.contributor.author | Badhe, Sachin | |
dc.date.accessioned | 2017-12-21T15:15:37Z | |
dc.date.available | 2017-12-21T15:15:37Z | |
dc.date.issued | 2016-08 | |
dc.identifier.citation | Higgins, M, Morgan-John, S, & Badhe, S 2016, 'Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use', Journal of Orthopaedics, 13, 4, pp. 401-403. | en |
dc.identifier.other | PMC4990659 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/1526 | |
dc.description.abstract | Over the past decade there have been increasing reports of atypical femoral fractures (AFFs) associated with bisphosphonate use. Reported cases of bilateral involvement usually refer to sequential injuries, or a complete fracture with an incomplete injury to the contralateral limb. In this case report we describe simultaneous, bilateral, complete atypical femoral fractures following a simple fall. A history of prodromal pain, previous radiological evidence of cortical thickening and long term alendronate therapy for osteoporosis secondary to corticosteroid treatment paint a classical picture of the presentation of an atypical fracture pattern of which orthopaedic surgeons should be aware. Crown Copyright (C) 2016 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of Prof. PK Surendran Memorial Education Foundation. All rights reserved. | en |
dc.language.iso | en | en |
dc.subject | Bisphosphonates | en |
dc.subject | Atypical femoral fracture | en |
dc.subject | Orthopaedics | en |
dc.subject | Osteoporosis | en |
dc.title | Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use. | en |
dc.type | Article | en |